NSEAnalysts/Institutional Investor Meet/Con. Call Updates26 Oct 2026 · 26 Oct 2026, 07:21 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Hikal Limited · HIKAL

✦ AI SummaryResults

Hikal Limited has informed the Exchange about the schedule of a meet to discuss the financial and operational performance of the Company for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Hikal Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

HIKAL_26102026192136_AnalystIntOct262026.pdf

pdf

Download →
View document text
October 26, 2026 BSE Limited, National Stock Exchange of India Limited, P J Towers, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Bandra, Mumbai - 400 001. Mumbai - 400 051. Scrip Code: 524735 Symbol: HIKAL Dear Sir/Madam, Subject: Intimation of earnings group conference call to discuss the financial and operational performance of the Company for the quarter and half year ended September 30, 2026. Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), this is to inform that, the Company will hold the earnings conference call to discuss the financial and operational performance of the Company for the quarter and half year ended September 30, 2026, on Tuesday, November 03, 2026, at 5:00 PM (IST). The details of the group conference call, including the dial-in details, are attached herewith. Thank you, Yours Sincerely, For Hikal Limited Rajasekhar Reddy Company Secretary & Compliance Officer Encl: As above Hikal Ltd. Admin. Office: Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India. Tel. + 91–22–6277 0299, + 91–22–6866 0300 Regd. Office: 717/718, Maker Chambers - 5, Nariman Point, Mumbai - 400 021, India. Tel. +91-22 6277 0477. Fax: + 91-22 6277 0500 www.hikal.com info@hikal.com CIN: L24200MH1988PTC048028 Hikal Limited Cordially invites you to Q2 & H1FY27 Post Results Conference Call scheduled on Tuesday, 3rd November 2026 at 05:00 PM (IST) Participants: Mr. Sameer Hiremath, Chairman and Managing Director Mr. Anish Swadi, CEO - Animal Health & Speciality Ingredients Mr. Kuldeep Jain, Chief Financial Officer Mr. Manoj Mehrotra, President, Pharmaceuticals Business Mr. Ravi Khadabadi, Business Head, Crop Protection & Speciality Chemicals Diamond Pass registration link: Click Here You are cordially invited Universal Access: +91 22 6280 1309, +91 22 7115 8210 International Numbers (Toll Free): Hong Kong: 800964448 | Singapore : 8001012045 UK : 08081011573 | USA : 18667462133 RSVP Strategic Growth Advisors Pvt. Ltd. Mr. Jigar Kavaiya | jigar.kavaiya@sgapl.net | +91 99206 02034 Ms. Ami Parekh | ami.parekh@sgapl.net | +91 80824 66052